Shots: Acc. to the US FDA, the recalling of the bottles is in response to the defective container with repeated complaints regarding its pump The solutions bottle with strength of 30mg/1.5mL is indicated as a replacement therapy in males with deficiency or absence of endogenous testosterone The class III recall of Testosterone bottles is done […]Read More
Tags : 752
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US